Reckitt Benckiser Group (OTCMKTS:RBGLY) Receives “Buy” Rating from UBS Group

UBS Group restated their buy rating on shares of Reckitt Benckiser Group (OTCMKTS:RBGLY) in a report released on Wednesday, The Fly reports.

Several other analysts have also recently issued reports on RBGLY. Barclays reiterated an overweight rating on shares of Reckitt Benckiser Group in a research note on Wednesday, September 30th. Credit Suisse Group reiterated a neutral rating on shares of Reckitt Benckiser Group in a research note on Wednesday, July 29th. Berenberg Bank restated a buy rating on shares of Reckitt Benckiser Group in a research report on Thursday, July 30th. JPMorgan Chase & Co. restated an overweight rating on shares of Reckitt Benckiser Group in a research report on Wednesday, July 29th. Finally, Zacks Investment Research upgraded shares of Reckitt Benckiser Group from a hold rating to a buy rating and set a $21.00 price objective on the stock in a research report on Wednesday. Three research analysts have rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the company. The company currently has an average rating of Hold and a consensus price target of $21.00.

OTCMKTS RBGLY opened at $18.44 on Wednesday. Reckitt Benckiser Group has a 1 year low of $12.76 and a 1 year high of $21.00. The company has a debt-to-equity ratio of 1.12, a current ratio of 0.83 and a quick ratio of 0.62. The stock has a market capitalization of $65.59 billion, a PE ratio of 20.49 and a beta of 0.69. The company’s 50 day simple moving average is $19.27 and its two-hundred day simple moving average is $18.52.

The firm also recently announced a Semi-Annual dividend, which was paid on Tuesday, October 6th. Investors of record on Friday, August 21st were given a $0.175 dividend. The ex-dividend date was Thursday, August 20th. Reckitt Benckiser Group’s payout ratio is presently 37.78%.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

See Also: High-Yield Dividend Stocks

The Fly

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.